3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
Cyclophosphamide
14
Temozolomide
11
Vincristine
9
Magnetic Resonance Spectroscopy
9
Cisplatin
9
Etoposide
8
Specimen Handling
7
Radiotherapy
7
X-Rays
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Lomustine
5
Carboplatin
5
Methotrexate
4
Irinotecan
4
Biopsy
4
etoposide phosphate
3
Thiotepa
3
Radiation
3
Platinum
3
Nivolumab
3
Filgrastim
3
Celecoxib
3
Bevacizumab
3
Automobiles
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
sargramostim
×
1 year
×
Clear all
No trials found.